Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curie Co is a private industrial biotechnology company developing sustainably derived ingredients for consumer goods using enzyme engineering, directed evolution, and biomanufacturing. The company focuses on replacing legacy petrochemical or otherwise problematic ingredients with bio-based alternatives for beauty and personal care, food and beverage, and adjacent markets. Its marketed products include Curamina for bond-building in hair care, Curabind for protein-rich food and dairy applications, and preservation systems such as AmpliPQ and Evogard. Curie Co positions itself as a platform-enabled ingredient innovator rather than a traditional therapeutics developer, leveraging biotechnology and conscious chemistry to create scalable commercial products. The company is headquartered in Durham, North Carolina and appears to be actively launching and partnering around new ingredient systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curie Co.